About ViroStat
ViroStat is a Healthcare company based in Portland (United States) founded in 1985, and was acquired by Medix Biochemica in November 2023. Infectious disease antibody reagents are supplied for diagnostics and research. ViroStat offers products and services including Antibodies, Antigens, Biospecimens, and Enzymes. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
ViroStat was founded in 1985 in Portland, United States, within the biotechnology sector focused on infectious diseases. Antibody tools, including over 500 reagents such as MONOTOPE monoclonal antibodies, OMNITOPE polyclonal antibodies, and recombinant antigens, are manufactured. Coverage includes virology, bacteriology, and parasitology. These products are distributed to researchers and diagnostic manufacturers globally.
- Headquarters Portland, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website virostat-inc.com
- Social LinkedIn Facebook YouTube
- Acquired by Medix Biochemica (Nov 2023)
- Investors
- Acquired byMedix Biochemica
(Nov 2023)
Products & Services of ViroStat
ViroStat offers a comprehensive portfolio of products and services, including Antibodies, Antigens, Biospecimens, and Enzymes.
Monoclonal antibodies for immunoassay tests in diagnostics.
Native and recombinant antigens for assay development.
Biological samples for research and quality control purposes.
Enzymes used in molecular reagents for diagnostics.
Apps and channels of ViroStat
its YouTube channel Medix Biochemica has 67 subscribers and 19 videos.
Videos from ViroStat
The most watched videos on ViroStat's YouTube channel, Medix Biochemica (67 subscribers). Click a video to play it here.
More on Medix Biochemica.
Investors in ViroStat
ViroStat has secured backing from 1 investor. Prominent investors backing the company include Medix Biochemica.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Develops and markets rapid diagnostic tests and bioreagents | 1985 | medixbiochemica.com | Espoo, Finland |
Investor details for ViroStat
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ViroStat
1 people are tracked at ViroStat (1 in leadership).
| Name | Role | Group |
|---|---|---|
Doug McAllister | president and founder | Leadership |
Complete people profiles for ViroStat
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ViroStat
2 dated milestones of ViroStat across 38 years, from founding to its latest funding, stage changes and deals.
- Founded ViroStat is founded.
- Exit Acquired by Medix Biochemica.
Competitors of ViroStat
ViroStat has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of ViroStat
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ViroStat
Websites that share an audience with ViroStat (virostat-inc.com).
Websites whose visitors overlap most with ViroStat. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| caymanchem.com | 100% | 393.1K | #148,469 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as ViroStat (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Virostat
Complete news archive for ViroStat
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ViroStat
ViroStat was founded in 1985.
ViroStat is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
ViroStat was founded in 1985 in Portland, United States, within the biotechnology sector focused on infectious diseases. Antibody tools, including over 500 reagents such as MONOTOPE monoclonal antibodies, OMNITOPE polyclonal antibodies, and recombinant antigens, are manufactured. Coverage includes virology, bacteriology, and parasitology. These products are distributed to researchers and diagnostic manufacturers globally.
ViroStat's top competitors include GenScript, Epitomics and Vector Laboratories.
ViroStat offers Antibodies, Antigens, Biospecimens, and Enzymes.
ViroStat has 1 investor. Key investors include Medix Biochemica.
Yes. ViroStat was acquired by Medix Biochemica in November 2023.